PTPN11 and RASopathy: With regard to the pathogenesis of RASopathy-related CHDs, studies on mouse models expressing NS-associated Ptpn11 variants studies indicate that elevated RAS-MAPK activation driven by overactive Ptpn11 results in aberrant endocardial cushion formation, eventually leading to valvuloseptal defects that are typical of NS [56,57].